|
USA-861102-Associations Company Direktoryo
|
Company News :
- People With Severe Diabetes Are Cured in Small Trial of New . . .
A person’s conventional supplies for treating type 1 diabetes A single infusion of a new treatment, called zimislecel, may have cured 10 out of 12 people with the most severe form of the disease
- Zimislecel, a novel cell therapy, appears to restore islet . . .
Results from the phase 1 2 portion of the FORWARD-101 trial, which enrolled patients with type 1 diabetes with severe hypoglycemic events and impaired hypoglycemic awareness, were presented at the
- People with Severe Type 1 Diabetes are Cured in Small Trial . . .
"A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of Type 1 diabetes," reports the New York Times "One year later, these 10 patients no longer need insulin The other two patients need much lower doses " The experimental treatment, cal
- Once-weekly insulin efsitora alfa versus once-daily insulin . . .
Efsitora showed non-inferior HbA1c reductions and similar rates of combined clinically significant or severe hypoglycaemia versus glargine U100 in participants with type 2 diabetes treated with basal and prandial insulin These findings show that efsitora is a well tolerated and efficacious once-weekly alternative to daily basal insulin, with a reduced injection frequency, for the treatment of
- Small trial in US of new treatment cures people with severe . . .
PressReader Catalog; For You; The Straits Times Small trial in US of new treatment cures people with severe diabetes 2025-06-22 - Gina Kolata A single infusion of a stem cellbased treatment may have cured 10 out of 12 people with the most severe form of Type 1 diabetes
- Oral Semaglutide Significantly Improves Cardiovascular . . .
In fact, people living with type 2 diabetes are more likely to develop and die from cardiovascular diseases, such as heart attacks, stroke, and heart failure than people who don’t have diabetes By eliminating the need for injections, oral semaglutide may improve adherence and support earlier initiation of therapy – broadening access to
- Decades in pursuit of a diabetes cure | Penn Medicine
That’s why patients may still experience severe long-term effects of diabetes even with insulin treatment: blindness, circulation problems, nerve damage, kidney failure, stroke, seizures—and, of course, hypoglycemic attacks
|
|